An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of Bahrain

NCT01205412 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 552

Last updated 2012-11-22

No results posted yet for this study

Summary

The purpose of this study is to determine the Human Papillomavirus (HPV) prevalence and HPV type distribution among women ≥ 20 years of age attending routine cervical screening and among women ≥ 16 years of age presenting for post-natal check up in the Kingdom of Bahrain.

Conditions

  • Human Papillomavirus Infection

Interventions

PROCEDURE

Endocervical samples

Endocervical samples collection during routine gynaecological examinations

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • Bahrain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01205412 on ClinicalTrials.gov